Article
Vutiglabridin improves neurodegeneration in MPTP-induced Parkinson’s disease mice by…
medRxiv · 2022 · Kang, S.; Choi, L. S.; Im, S.; Lee, K. W.; Kim, D. H.; Park, J. H.; Park, M.-H.; Lee, J.; Park, S. K.; Kim, K. P.; Lee, H. M.; Jeon, H. J.; Park, H. S.; Yoo, S.-K.; Kim Pak, Y.
Key facts
| Title | Vutiglabridin improves neurodegeneration in MPTP-induced Parkinson’s disease mice by targeting mitochondrial paraoxonase-2 |
|---|---|
| First author | Kang, S.; Choi, L. S.; Im, S.; Lee, K. W.; Kim, D. H.; Park, J. H.; Park, M.-H.; Lee, J.; Park, S. K.; Kim, K. P.; Lee, H. M.; Jeon, H. J.; Park, H. S.; Yoo, S.-K.; Kim Pak, Y. |
| Journal | medRxiv |
| Published | Oct 21, 2022 |
| DOI | 10.1101/2022.10.20.512990 |
| Devices mentioned | K040782, K801561, K802418, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 5 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, JAK, JQB and 7 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1